Two steps forward, one step back – news on access to CDKs in second line treatment

Hello everyone, BCNA has an update on access to CDKs as second line treatment. Pfizer have this week advised BCNA about a new capped access program for the CDK inhibitor palbociclib (lbrance) wh...